Jennifer Saultz, D.O., receives a 2022 American Society of Hematology scholar award, presented to hematologists in the United States and Canada who conduct basic, translational or clinical research.

Aluko Hope, M.D., discusses OHSU's Long COVID-19 program and says the issue "... will be sort of the post-pandemic challenge of our time."

A tweet from Esther Choo, M.D., is featured in a The New York Times story warning the end of the omicron surge should not be confused with the end of the pandemic.

The new Doernbecher Freestyle XVII collection, featuring creative Nike shoe and apparel designed by inspirational OHSU Doernbecher patients, is unveiled to an international audience.

Looking ahead to the next stages of the pandemic and beyond, Kevin Winthrop, M.D., and Marcel Curlin, M.D., discuss five key steps Oregon should take, including setting public expectations, increasing vaccinations and boosters, improve indoor air, test wastewater, and stockpile supplies.

A new study led by Andrea Stroud, M.D., finds women who are obese and undergo bariatric surgery could reduce their risk of breast cancer by half: "Our review highlights recent publications linking bariatric surgery to decreased breast cancer incidence, discusses possible consequences of bariatric surgery on breast cancer screening, and finally proposes bariatric surgery as a potential preventative and adjuvant therapy for breast cancer."

In response to new heat and smoke safety rules proposed by OSHA, OHSU facilities technician Mark Chapman says: "People experience heat stress at different levels due to their own metabolism and fitness.

Cong-Qiu Chu, M.D., Ph.D., discusses the four stages of rheumatoid arthritis.

A new test aims to match cancer patients to therapy options using both whole-exome sequencing and RNA transcriptome sequencing. Gordon Mills, M.D., Ph.D., says: "Monitoring the TME (tumor microenvironment) will become part of therapy similar to assessing the tumor in the future. However, this is likely to be a gradual process with the implication of TME markers being validated in prospective clinical trials followed by approval by the FDA for specific roles in patient decision-making."

The Feb. 24 forecast by Peter Graven, Ph.D., notes the number of Oregonians hospitalized with COVID-19 continues to decline and will reach levels last seen before the arrival of the highly contagious omicron variant around March 12.